Salanti, Ali
Clausen, Thomas M.
Agerbæk, Mette Ø.
Al Nakouzi, Nader
Dahlbäck, Madeleine
Oo, Htoo Z.
Lee, Sherry
Gustavsson, Tobias
Rich, Jamie R.
Hedberg, Bradley J.
Mao, Yang
Barington, Line
Pereira, Marina A.
LoBello, Janine
Endo, Makoto
Fazli, Ladan
Soden, Jo
Wang, Chris K.
Sander, Adam F.
Dagil, Robert
Thrane, Susan
Holst, Peter J.
Meng, Le
Favero, Francesco
Weiss, Glen J.
Nielsen, Morten A.
Freeth, Jim
Nielsen, Torsten O.
Zaia, Joseph
Tran, Nhan L.
Trent, Jeff
Babcook, John S.
Theander, Thor G.
Sorensen, Poul H.
Daugaard, Mads
Funding for this research was provided by:
Novo Nordisk Foundation
Danish Cancer Society
Stand Up To Cancer
St. Baldrick’s Pediatric Dream Team Translational Research (SU2C-AACR-DT1113)
American Association for Cancer Research
Augustinus Foundation
U.S. Department of Defense
Harboe Foundation
European Research Councils
The Danish Innovation Foundation
VAR2 Pharmaceuticals
Kairos Therapeutics
Spar Nord Foundation
Team Finn
Prostate Cancer Canada (PCC) Foundation
This article is maintained by: Elsevier
Article Title: Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Journal Title: Cancer Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2015.09.003
Content Type: article
Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.